R2 Surgical, a leading provider of pre-owned robotic surgical systems, will be attending The Surgeon Show, where it will join surgeons, healthcare leaders and surgical businesses to discuss the future of advanced surgical technology and improved patient access.
Founded in 2019, R2 Surgical pioneered the sourcing and global distribution of pre-owned da Vinci surgical robots with the belief that every patient should have access to advanced robotic surgery. The company was created to address the high-cost barriers associated with new robotic systems, which can prevent many hospitals from offering minimally invasive procedures.
Robotic surgery is widely recognized for its benefits, including smaller incisions, reduced patient discomfort, faster recovery times and proven clinical outcomes. R2 Surgical works to ensure these advantages are not limited to well-funded institutions by making robotic surgery more affordable for hospitals and ambulatory surgery centers worldwide.
By delivering da Vinci Si and Xi systems at accessible price points, R2 Surgical is expanding the reach of robotic-assisted surgery to more healthcare providers. Each system undergoes rigorous component-level assessment, technical validation and certification before being deployed to healthcare facilities across the globe.
In addition to equipment sourcing and distribution, R2 Surgical provides comprehensive technical support services to ensure long-term success. This includes the continuous supply of instruments and consumables, specialized clinical training for surgical teams, responsive technical support and validated sterilization and maintenance protocols.
As pioneers in the pre-owned surgical robotics market, the company has supported hospitals, universities and medical centers across Europe, North America, South America and beyond.
Commenting on R2 Surgical’s attendance at The Surgeon Show, Tom Shrader, Founder of R2 Surgical, said: “Robotic surgery should not be a privilege reserved for a small number of well-funded institutions. At R2 Surgical, our mission is to make advanced robotic technology accessible to more hospitals around the world, without compromising on safety, performance or clinical outcomes. The Surgeon Show is a valuable opportunity to engage with the surgical community and demonstrate how pre-owned robotic systems can transform patient care in a sustainable and affordable way.”
R2 Surgical’s impact can be seen in healthcare institutions worldwide, including Plaza Medical Clinic in Dnipro, Ukraine, Atasam Hospital in Northern Turkey, The Prostate Clinic in Nigeria, and Instituto Médico La Floresta in Venezuela, where affordable robotic systems have helped optimize budgets while improving patient care.
The company was founded by Tom Shrader, whose vision was to revolutionize access to advanced surgical technology. What began as a small operation quickly grew into a specialized organization supported by experienced consultants, field trainers, and certified sterile processing professionals, ensuring hospitals receive support well beyond the point of installation.
By attending The Surgeon Show, R2 Surgical looks forward to connecting with the surgical community, sharing expertise and demonstrating how pre-owned robotic systems can play a vital role in making advanced surgery more accessible, sustainable and fully supported.
The Surgeon Show is a dynamic, conversation-led gathering where every perspective counts and every voice can shape the future of surgical practice. From main stage sessions to breakout discussions, the event encourages open dialogue on what truly matters in modern surgery from the operating theatres of the future to the transformative power of AI, robotics and new technologies.
🗓️ February 20, 2026
📍 London, UK
💬 @The Surgeon Show
🤝 Request a meeting
The Surgeon Show is invitation only. For more information and to register your interest, click here.